Selling Stem Cells in the USA: Assessing the Direct-to-Consumer Industry

Leigh Turner, Paul Knoepfler

Research output: Contribution to journalComment/debatepeer-review

196 Scopus citations

Abstract

Direct-to-consumer marketing of unapproved stem cell interventions is a well-known phenomenon in countries with lax medical regulations. However, an examination of Internet-based marketing claims revealed widespread promotion of such interventions by businesses based in the United States. Such commercial activity suggests that regulatory agencies must better oversee this marketplace.

Original languageEnglish (US)
Pages (from-to)154-157
Number of pages4
JournalCell Stem Cell
Volume19
Issue number2
DOIs
StatePublished - Aug 4 2016

Bibliographical note

Publisher Copyright:
© 2016 Elsevier Inc.

Fingerprint

Dive into the research topics of 'Selling Stem Cells in the USA: Assessing the Direct-to-Consumer Industry'. Together they form a unique fingerprint.

Cite this